Company research / FLGT
Fulgent Genetics, Inc. (FLGT)
- Sector Services
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Fulgent Genetics, Inc. reported revenue of $322.67M. Revenue grew 13.8% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $323.93M.
Key ratios (year ended 2025-12-31)
40.6%
Gross margin
-28.2%
Operating margin
-18.8%
Net margin
-5.4%
Return on year-end equity
13.8%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.